According to MarketsandMarketstm, the Next-Generation Sequencing Market is projected to grow from about USD 14.94 billion in ...

For more than 40 years, Florida Cancer Specialists & Research Institute (FCS) has embraced innovation to deliver world-class care and drive the dramatic transformation of oncology care through its ...

Prostate cancer (PCa) is one of the most common malignant tumors among men worldwide. Following androgen deprivation therapy ...

Biomarker testing is crucial for personalized oncology care, aiding in risk stratification and treatment decisions, but faces ...

Workers represented by Teamsters Local 120 at Sturgis Ambulance have ratified their first collective bargaining agreement.

As of Friday, January 23, Burning Rock Biotech Limited’s BNR share price has dipped by 9.56%, which has investors questioning if this is right time to buy.

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced ...

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) (the “Company”) today announced the successful completion of its acquisition of Halda Therapeutics OpCo, Inc. (“Halda”), a ...

Regulatory deregulation and liquid biopsy adoption pushing the rapid growth of the oncology companion diagnostic market. In ...

Johnson & Johnson (NYSE: JNJ) (the “Company”) today announced the successful completion of its acquisition of Halda Therapeutics OpCo, Inc. (“Halda”), a clinical-stage biotechnology company with a ...

New data show cancer survival has reached a record high — nearly 70% of patients now live at least five years after diagnosis ...

The firm is focused on helping pharma characterize response and resistance to their drugs, with the hope of getting a companion diagnostic approval.